The global recombinant proteins market is projected to reach USD 1.7 billion by 2026

From USD 1.0 billion in 2021 to USD 1.7 billion in 2026, the worldwide recombinant proteins market is expected to grow at a CAGR of 9.8% over the forecast period.



Growth factors and chemokines accounted for the greatest proportion of the recombinant proteins market in 2020, and this segment is predicted to increase at the fastest CAGR during the forecast period.

Growth factors and chemokines, structural proteins, kinase proteins, regulatory proteins, membrane proteins, recombinant metabolic enzymes, adhesion molecules and receptors, immune response proteins, and other recombinant proteins are the different types of recombinant proteins.The application of growth factors and chemokines in many research areas such as chemotaxis, neurobiology, wound healing, immunology, transplantation, apoptosis, cancer, HIV/AIDS, COVID-19, cell culture, and stem cell research accounts for a major share of the growth factors and chemokines segment.

During the projected period, the drug discovery and development segment is expected to increase at the fastest CAGR.

Drug discovery and development, biopharmaceutical production, biotechnology research, academic research projects, and other applications make up the recombinant proteins market. In 2020, drug discovery and development held the greatest share of the application segment, and it is also predicted to increase at the fastest CAGR over the forecast period. Recombinant proteins are vital and the most critical component of small molecule drug development programmes because they are indispensable research tools in many fields of biology. Recombinant proteins aid in the discovery and development of novel drugs that impact disease-associated protein activity. In the next years, increased research and development in this category is likely to benefit the overall growth of the recombinant proteins market.

North America was the largest regional market for the recombinant proteins market in 2019

North America, Europe, Asia Pacific, and the Rest of the World are the four major regions in which recombinant proteins are sold (RoW). In 2020, the largest regional market for recombinant proteins was North America. The presence of the majority of key players operating in the recombinant proteins market in North America accounts for the region's large share of the industry.Other factors projected to enhance the market for recombinant proteins in this region include rising chronic and infectious illness occurrences, increased R&D investment, increased research activity in the fields of proteomics and genomics, and attractive government funding opportunities.

During the projected period, however, the Asia Pacific market is expected to develop at the fastest CAGR. The presence of emerging economies such as China, India, and South Korea; these countries' large population bases and rising prevalence of chronic diseases; improving living standards and the growing demand for quality medical care; increased healthcare spending and government initiatives; growth in the demand for diagnostics; increased research activities; and the rising number of collaborations for life science research studies are some of the major factors driving the growth of this regional market.

The global market for recombinant proteins is fragmented. The prominent players operating in this market include Thermo Fisher Scientific, Inc. (US), Miltenyi Biotech (Germany), Sino Biological Inc. (China), Merck KGaA (Germany), Abcam plc (UK), Biolegend (US), Bio-Rad Laboratories, Inc. (US), GenScript Biotech Corporation (China), Enzo Life Sciences, Inc. (US), BPS Bioscience, Inc. (US), PeproTech, Inc. (US), Proteintech Group, Inc. (US), Abnova Corporation (Taiwan), R&D Systems (US), STEMCELL Technologies Inc (Canada), Other players operating in the market include RayBiotech Inc (US), CellGenix GmbH (Germany), ACROBiosystems (US), ProSpec-TechnoGene Ltd. (Israel), Neuromics (US), RICHCORE LIFESCIENCES PVT LTD (India), Icosagen AS (US), ProteoGenix (France), United States Biological (US), StressMarq Biosciences Inc (Canada), and Aviva Systems Biology Corporation (US)  are one of the leading companies in this market.

Comments

Post a Comment

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

Image
CGM (Continuous Glucose Monitoring) technology allows you to monitor your glucose levels 24 hours a day using a sensor that delivers the data to a MiniMed insulin pump. However, these devices also aid in diabetes management by lowering individual insulin dosages. These gadgets' integrated software provides users with information about food consumption, medication, physical activity, and ailments.  As a result, an increasing number of diabetic patients are relying on these devices to control and treat their condition, propelling market growth. A growing number of continuous glucose monitoring devices are being integrated with apps and software to treat people with diabetes mellitus, thanks to the development of digital medicines.The rising prevalence of diabetes mellitus has boosted the market for continuous glucose monitoring (CGM) devices. The Continuous Glucose Monitoring (CGM) Market is estimated to develop at a CAGR of 14% over the forecast period. High blood glucose levels oc...
Read more

YOU YES YOU!

Image
Welcome to Riya's  blog! HEY Everyone! So this is my my very first blog and  i am quite excited about it. WELL  I am  a 21 years old girl who sees the world through her eyes just like everyone else. I believe each of us have their own views and opinions about every little thing that we see through our eyes wide open and that is  what individuality is ! Having our own brains , hobbies,rights,skills , gifts ,flaws and i certainly believe that embracing them is one of the best things a human could do. Okay well so the topic on what  i am going to throw a little  light on here is not self love or self respect or being righteous , strong or anything like that , My topic here is going to be "YOU"   . "YOU" can be anyone here including me 'YOU' = "Individual" Isn't it so weird that in a world having  millions and millions of people  with their own "IDENTITIES " still lack " INDIVIDUALITY ". You know why? because...
Read more

Key Benefits of Breath Analyzer Market

Image
The Breath Analyzer is a gadget that uses a breath sample to determine an individual's Blood Alcohol Content (BAC). The test is based on the link between the amount of alcohol in the blood and the amount of alcohol in the breath going through the lungs. The use of breath analyzer equipment has increased as the trend for severe alcohol intake has increased, resulting in traffic accidents.  Government actions that favor the market are also propelling it forward. Breathalyzer devices are also gaining popularity as a result of the growing demand for accurate BAC (blood alcohol content) levels at work, as well as their non-invasive nature, which is driving up demand for breath analyzer equipment. It's a must-have tool for keeping track of drugs, alcohol, TB, and asthma. and other diseases hence; it is projected that the demand for this system should constantly rise.  Inaccurate analysis, on the other hand, might lead to wrong diagnosis, which is the market's main constrai...
Read more